Comment re: "Sporadic aberrant crypt foci are not a surrogate endpoint for colorectal adenoma prevention" and "Aberrant crypt foci in the adenoma prevention with celecoxib trial"

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer prevention research (Philadelphia, Pa.) Pa.), 2008-08, Vol.1 (3), p.215-216
Hauptverfasser:	Stevens, Richard G, Pretlow, Theresa P, Hurlstone, D Paul, Giardina, Charles, Rosenberg, Daniel W
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenoma - diagnosis Adenoma - pathology Adenoma - prevention & control Antineoplastic Agents - therapeutic use Biomarkers - analysis Celecoxib Chemoprevention - methods Clinical Trials as Topic Colorectal Neoplasms - diagnosis Colorectal Neoplasms - pathology Colorectal Neoplasms - prevention & control Consensus Early Detection of Cancer Humans Intestinal Mucosa - pathology Precancerous Conditions - diagnosis Precancerous Conditions - pathology Pyrazoles - therapeutic use Sulfonamides - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!